GILL JOHN

CIK 00014099392 companiesANNAPOLIS, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001409939

Recent Transactions

35 trades

Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2025-09-25+48,800→ 48,800 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2024-09-26+34,900→ 34,900 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2023-09-28+26,100→ 26,100 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2022-09-29+23,500→ 23,500 total
Sale
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-08-12$15.00/sh−2,714→ 2,771 total
Gift
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-01-06−2,714→ 0 total
Gift
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2021-12-27−2,714→ 2,771 total
Gift
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2021-12-27−2,714→ 5,485 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2021-09-23+24,100→ 24,100 total
Gift
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2021-05-03−3,000→ 8,199 total
Sale
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2020-11-30$11.92/sh−8,425→ 11,199 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2020-09-24+25,500→ 25,500 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2020-09-24+16,850→ 19,624 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units ("RSUs")
2020-09-24−16,850→ 0 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units ("RSUs")
2020-06-25+16,850→ 16,850 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2019-01-02+20,000→ 20,000 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2017-10-13+20,000→ 20,000 total
Purchase
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2017-06-02$4.34/sh+1,000→ 83,224 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, $0.0001 par value per share
2016-11-22$2.20/sh+100,000→ 822,244 total
Exercise/Conversion
Altimmune, Inc.$ALT
Employee Stock Option (right to buy)
2016-11-22−100,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001 per share
2016-09-16$2.59/sh+10,000→ 702,244 total
Exercise/Conversion
Altimmune, Inc.$ALT
Employee Stock Option (right to buy)
2016-09-16−20,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Employee Stock Option (right to buy)
2016-09-16−10,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001 per share
2016-09-16$2.47/sh+20,000→ 722,244 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001 per share
2016-09-15$1.60/sh+20,000→ 632,244 total
Exercise/Conversion
Altimmune, Inc.$ALT
Employee Stock Option (right to buy)
2016-09-15−20,000→ 0 total
Award
Altimmune, Inc.$ALT
Stock option (right to buy)
2016-06-01$2.20/sh+100,000→ 100,000 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001 per share
2015-11-05+612,244→ 612,244 total
Award
Altimmune, Inc.$ALT
Stock option (right to buy)
2013-06-11+20,000→ 20,000 total
Award
Altimmune, Inc.$ALT
Stock option (right to buy)
2012-06-22+20,000→ 20,000 total
Award
Altimmune, Inc.$ALT
Stock option (right to buy)
2011-06-23+20,000→ 20,000 total
Award
Altimmune, Inc.$ALT
Stock option (right to buy)
2010-06-23+20,000→ 20,000 total
Award
Altimmune, Inc.$ALT
Option to Purchase
2009-08-14+40,000→ 40,000 total
Award
Altimmune, Inc.$ALT
Stock Option (right to buy)
2009-08-05+20,000→ 20,000 total
Award
Altimmune, Inc.$ALT
Stock option (right to buy)
2009-03-09+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450

ANNAPOLIS, MD, 21401

View on SEC.gov